Anne-Marie Mes-Masson
Université de Montréal
H-index: 84
North America-Canada
Top articles of Anne-Marie Mes-Masson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Correction to: Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution | Skye Alexandre Sauriol Ricard Frédéric Leblond Anne-Marie Mes-Masson Thomas Gervais | 2024 | |
Author Correction: Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly (ADP-ribose) polymerase inhibitor resistance in high-grade … | Scientific reports | Skye Alexandre Sauriol Euridice Carmona Molly L Udaskin Nikolina Radulovich Kim Leclerc-Desaulniers | 2024/5/1 |
Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data | The French Journal of Urology | C Dariane F Chierigo V Ouellet N Delvoye M-P Jammal | 2024/1/1 |
The journey from bench to bedside–it takes a science village | Anne-Marie Mes-Masson | 2024/4/19 | |
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages | Frontiers in Immunology | Sarah Nersesian Riley J Arseneau Jorge P Mejia Stacey N Lee Lauren P Westhaver | 2024/1/22 |
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth | Cancers | Jorgelindo da Veiga Moreira Nancy Nleme Laurent Schwartz Kim Leclerc-Desaulniers Euridice Carmona | 2024/1/13 |
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly (ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer | Scientific Reports | Alexandre Sauriol Euridice Carmona Molly L Udaskin Nikolina Radulovich Kim Leclerc-Desaulniers | 2023/2/27 |
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma | Frontiers in Oncology | Julyanne Brassard Michael R Hughes Pamela Dean Diana Canals Hernaez Shelby Thornton | 2023 |
Exactis-03: A phase I trial of the combination of olaparib and navitoclax in women with high grade serous ovarian cancer and triple negative breast cancer. | Helen Mackay Anne-Marie Mes-Masson Francis Rodier Stephanie Lheureux Katarzyna Joanna Jerzak | 2023/6/1 | |
Pixelated microfluidics for drug screening on tumour spheroids and ex vivo microdissected tumour explants | Cancers | Dina Dorrigiv Pierre-Alexandre Goyette Amélie St-Georges-Robillard Anne-Marie Mes-Masson Thomas Gervais | 2023/2/7 |
53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer | bioRxiv | Michael Skulimowski Jessica Bourbonnais Nicolas Malaquin Hubert Fleury Isabelle Clement | 2023 |
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer. | Anna Jeter Alba Galan Arturo Papaluca Ali Nejatie Emad Matanes | 2023/6/1 | |
A senescence-like state is beneficial for ovarian cancer treatment | bioRxiv | Michael Skulimowski Llilians Calvo Gonzalez Shuofei Cheng Isabelle Clement Lise Portelance | 2023 |
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways | Cancer Letters | Louis Lacombe Hélène Hovington Hervé Brisson Sadia Mehdi Déborah Beillevaire | 2023/1/28 |
Medium-embedded samples | 2023/4/6 | ||
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy | Oncoimmunology | David Henault David Stephen Pierre-Antoine St-Hilaire Nouredin Messaoudi Franck Vandenbroucke-Menu | 2023/12/31 |
Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer | medRxiv | Larissa Milano Wejdan M Alenezi Caitlin Fierheller Corrine Serruya Timothee Revil | 2023 |
Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases | Frontiers in Oncology | Wejdan M Alenezi Caitlin T Fierheller Corinne Serruya Timothée Revil Kathleen K Oros | 2023/3/8 |
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene | Genes | Caitlin T Fierheller Wejdan M Alenezi Corinne Serruya Timothée Revil Setor Amuzu | 2023/1/20 |
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer | Nature Communications | Carolin M Sauer James A Hall Dominique-Laurent Couturier Thomas Bradley Anna M Piskorz | 2023/10/16 |
